199 related articles for article (PubMed ID: 28711987)
1. Getting genetic access to natural adenovirus genomes to explore vector diversity.
Zhang W; Ehrhardt A
Virus Genes; 2017 Oct; 53(5):675-683. PubMed ID: 28711987
[TBL] [Abstract][Full Text] [Related]
2. Development of an AdEasy-based system to produce first- and second-generation adenoviral vectors with tropism for CAR- or CD46-positive cells.
Janssen JM; Liu J; Skokan J; Gonçalves MA; de Vries AA
J Gene Med; 2013 Jan; 15(1):1-11. PubMed ID: 23225636
[TBL] [Abstract][Full Text] [Related]
3. Development of Novel Adenoviral Vectors to Overcome Challenges Observed With HAdV-5-based Constructs.
Alonso-Padilla J; Papp T; Kaján GL; Benkő M; Havenga M; Lemckert A; Harrach B; Baker AH
Mol Ther; 2016 Feb; 24(1):6-16. PubMed ID: 26478249
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy.
Thirion C; Lochmüller H; Ruzsics Z; Boelhauve M; König C; Thedieck C; Kutik S; Geiger C; Kochanek S; Volpers C; Burgert HG
Hum Gene Ther; 2006 Feb; 17(2):193-205. PubMed ID: 16454653
[TBL] [Abstract][Full Text] [Related]
5. Human AdV-20-42-42, a Promising Novel Adenoviral Vector for Gene Therapy and Vaccine Product Development.
Ballmann MZ; Raus S; Engelhart R; Kaján GL; Beqqali A; Hadoke PWF; van der Zalm C; Papp T; John L; Khan S; Boedhoe S; Danskog K; Frängsmyr L; Custers J; Bakker WAM; van der Schaar HM; Arnberg N; Lemckert AAC; Havenga M; Baker AH
J Virol; 2021 Oct; 95(22):e0038721. PubMed ID: 34469243
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy.
Wilkinson-Ryan I; Kim J; Kim S; Ak F; Dodson L; Colonna M; Powell M; Mutch D; Spitzer D; Hansen T; Goedegebuure SP; Curiel D; Hawkins W
PLoS One; 2015; 10(5):e0125851. PubMed ID: 25933160
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75.
Zhang W; Mese K; Schellhorn S; Bahlmann N; Mach N; Bunz O; Dhingra A; Hage E; Lafon ME; Wodrich H; Heim A; Ehrhardt A
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32887347
[TBL] [Abstract][Full Text] [Related]
8. Modified adenoviral vectors ablated for coxsackievirus-adenovirus receptor, alphav integrin, and heparan sulfate binding reduce in vivo tissue transduction and toxicity.
Koizumi N; Kawabata K; Sakurai F; Watanabe Y; Hayakawa T; Mizuguchi H
Hum Gene Ther; 2006 Mar; 17(3):264-79. PubMed ID: 16544976
[TBL] [Abstract][Full Text] [Related]
9. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
[TBL] [Abstract][Full Text] [Related]
10. Transduction Enhancers Enable Efficient Human Adenovirus Type 5-Mediated Gene Transfer into Human Multipotent Mesenchymal Stromal Cells.
Nilson R; Lübbers O; Weiß L; Singh K; Scharffetter-Kochanek K; Rojewski M; Schrezenmeier H; Zeplin PH; Funk W; Krutzke L; Kochanek S; Kritzinger A
Viruses; 2021 Jun; 13(6):. PubMed ID: 34204818
[TBL] [Abstract][Full Text] [Related]
11. State-of-the-art human adenovirus vectorology for therapeutic approaches.
Gao J; Mese K; Bunz O; Ehrhardt A
FEBS Lett; 2019 Dec; 593(24):3609-3622. PubMed ID: 31758807
[TBL] [Abstract][Full Text] [Related]
12. Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.
Ruzsics Z; Wagner M; Osterlehner A; Cook J; Koszinowski U; Burgert HG
J Virol; 2006 Aug; 80(16):8100-13. PubMed ID: 16873266
[TBL] [Abstract][Full Text] [Related]
13. In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor.
Smith T; Idamakanti N; Kylefjord H; Rollence M; King L; Kaloss M; Kaleko M; Stevenson SC
Mol Ther; 2002 Jun; 5(6):770-9. PubMed ID: 12027562
[TBL] [Abstract][Full Text] [Related]
14. Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity.
Schulick AH; Vassalli G; Dunn PF; Dong G; Rade JJ; Zamarron C; Dichek DA
J Clin Invest; 1997 Jan; 99(2):209-19. PubMed ID: 9005989
[TBL] [Abstract][Full Text] [Related]
15. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells.
Jakubczak JL; Rollence ML; Stewart DA; Jafari JD; Von Seggern DJ; Nemerow GR; Stevenson SC; Hallenbeck PL
J Virol; 2001 Mar; 75(6):2972-81. PubMed ID: 11222722
[TBL] [Abstract][Full Text] [Related]
17. Identification of novel human adenovirus candidates using the coxsackievirus and adenovirus receptor for cell entry.
Mese K; Bunz O; Schellhorn S; Volkwein W; Jung D; Gao J; Zhang W; Baiker A; Ehrhardt A
Virol J; 2020 Apr; 17(1):52. PubMed ID: 32272960
[TBL] [Abstract][Full Text] [Related]
18. Porcine adenovirus serotype 3 internalization is independent of CAR and alphavbeta3 or alphavbeta5 integrin.
Bangari DS; Mittal SK
Virology; 2005 Feb; 332(1):157-66. PubMed ID: 15661148
[TBL] [Abstract][Full Text] [Related]
19. Laboratory-Scale Production of Replication-Deficient Adenovirus Vectored Vaccines.
Morris SJ; Turner AV; Green N; Warimwe GM
Methods Mol Biol; 2016; 1349():121-35. PubMed ID: 26458833
[TBL] [Abstract][Full Text] [Related]
20. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli.
Hoffmann D; Wildner O
BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
